Healthcare & Life Sciences
Healthcare and life sciences organizations navigate strict regulatory environments such as HIPAA and FDA 21 CFR Part 11 while handling sensitive patient data and intellectual property. The Replica platform enables isolated testing of connected medical devices, safe evaluation of third-party healthcare technologies, and compliant cross-institutional research collaboration, all performed in completely isolated environments that prevent exposure risks to clinical systems. From pharmaceutical development to clinical trials to experimental research, the platform provides the isolation needed to conduct potentially risky cybersecurity operations and innovative activities without compromising your production environment or regulatory standing, while eliminating risks of data leakage and IP theft.
Protect proprietary methodologies, clinical research data, and experimental findings within isolated environments that eliminate risk of data leakage or IP theft.
Conduct security testing, incident response, and threat hunting for healthcare-specific attacks without exposing clinical systems or patient data.
Maintain detailed, verifiable records of all research activities that support FDA submissions, clinical trial documentation, and regulatory inspections.
Facilitate secure, controlled access for distributed research teams and external partners without exposing sensitive data or methodologies.
Replica enables healthcare and life sciences organizations to overcome the tension between innovation speed and regulatory compliance, while empowering their cybersecurity teams to protect sensitive assets. Our platform accelerates research and clinical trials while ensuring all activity meets strict documentation standards. Security teams can safely investigate healthcare-specific threats, test medical device vulnerabilities, and validate vendor security claims without risking patient data or clinical systems.
